- Nephrogenic Systemic Fibrosis
-
An WS
- KMID: 2307147
- Korean J Nephrol.
- 2011 Jan;30(1):125-128.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Nephrogenic Fibrosing Dermopathy Improved after Renal Transplantation
-
Kim HS, Kim SH, Ko HC, Kim MB, Song SH, Kim JS, Kwak IS
- KMID: 2247717
- Korean J Dermatol.
- 2010 Feb;48(2):143-147.
Nephrogenic fibrosing dermopathy (NFD) is a rare cutaneous fibrosing disorder that primarily affects patients with a history of renal disease. NFD manifests with induration, thickening and hardening of the skin... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Delayed Onset Nephrogenic Systemic Fibrosis After Gadolinium Based Contrast Injection
-
Do JG, Kim YB, Lee DG, Hwang JH
- KMID: 2383668
- Ann Rehabil Med.
- 2012 Dec;36(6):880-886.
Nephrogenic systemic fibrosis (NSF) is a rare fibrosing disorder of the skin and joints that occurs in patients with advanced renal insufficiency. This condition is progressive and can be seriously... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of nephrogenic systemic fibrosis after gadolinium-based contrast agent injection
-
Hong MH, Koo HM, Choi J, Ahn JR, Chon HJ, Kim C, Lee ST
- KMID: 2259215
- Korean J Med.
- 2010 Jan;78(1):127-131.
Nephrogenic systemic fibrosis is a rare multisystemic disorder mainly affecting the skin and joints in patients with underlying renal insufficiency exposed to gadolinium-based contrast. We report a patient who had... -
- CITED
-
- Close
- SHARE
-
- Close
- Prevention of Nephrogenic Systemic Fibrosis
-
Lee DW
- KMID: 2082585
- Korean J Med.
- 2015 Mar;88(3):267-272.
- doi: 10.3904/kjm.2015.88.3.267
Gadolinium is widely used as a contrast agent for magnetic resonance imaging (MRI). In patients with radiocontrast media-induced nephrotoxicity, MRI has generally been considered to be a safe substitute for... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of nephrogenic systemic fibrosis following gadolinium exposure in a peritoneal dialysis patient
-
Koo TH, Lee DH, Baek HK, Kim DK, Kim BK, Hong SH, An WS
- KMID: 2259168
- Korean J Med.
- 2010 Apr;78(4):507-511.
Nephrogenic systemic fibrosis is a systemic illness that only affects patients with kidney failure. Exposure to gadolinium-based contrast agents has been associated with the subsequent development of nephrogenic systemic fibrosis... -
- CITED
-
- Close
- SHARE
-
- Close
- Nephrogenic Systemic Fibrosis with Myopathy
-
Heo DH, Jang IM, Roh H, Ahn MY, Jin SY
- KMID: 2203112
- J Korean Soc Clin Neurophysiol.
- 2012 Jun;14(1):36-40.
Nephrogenic systemic fibrosis (NSF) is a systemic disease that affects the skin and other tissues in patients with renal insufficiency and exposure to gadolinium-containing contrast. A 55-year-old woman with end-stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Gadolinium Deposition in the Brain: Current Updates
-
Choi JW, Moon WJ
- KMID: 2429927
- Korean J Radiol.
- 2019 Jan;20(1):134-147.
- doi: 10.3348/kjr.2018.0356
Gadolinium-based contrast agents (GBCAs) are commonly used for enhancement in MR imaging and have long been considered safe when administered at recommended doses. However, since the report that nephrogenic systemic... -
- CITED
-
- Close
- SHARE
-
- Close
- Contrast Enhanced US in the Abdomen
-
Chung YE, Kim KW
- KMID: 1427214
- J Korean Soc Ultrasound Med.
- 2012 Dec;31(4):203-212.
Contrast enhanced ultrasound, which was introduced in 1996, has been widely used in Europe and Eastern Asia. Ultrasound contrast agent can be classified as first generation and second generation, depending... -
- CITED
-
- Close
- SHARE
-
- Close
- In vivo Imaging Biodistribution Profile of a New Macrocyclic Gadolinium Chelate as a Highly Stable Multifunctional MRI Contrast Agent
-
Sung BK, Jo YW, Chang Y
- KMID: 2442231
- Investig Magn Reson Imaging.
- 2019 Mar;23(1):34-37.
- doi: 10.13104/imri.2019.23.1.34
Gadolinium contrast agents (CAs) are integral components of clinical magnetic resonance imaging (MRI). However, safety concerns have arisen regarding the use of gadolinium CAs, due to their association with nephrogenic... -
- CITED
-
- Close
- SHARE
-
- Close
- CO2 Angiography-1
-
Park JS
- KMID: 1448079
- Korean J Vasc Endovasc Surg.
- 2011 May;27(2):52-60.
- doi: 10.5758/kjves.2011.27.2.52
CO2 was firstly used as an intravenous contrast medium in the early 1950s for diagnosing pericardial effusion. In the 1970s Cho and Hawkins pioneered the intraarterial use of CO2. In... -
- CITED
-
- Close
- SHARE
-
- Close
